211 related articles for article (PubMed ID: 18826388)
1. Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura.
Kuwana M; Okazaki Y; Ikeda Y
J Thromb Haemost; 2009 Feb; 7(2):322-9. PubMed ID: 18826388
[TBL] [Abstract][Full Text] [Related]
2. The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura.
Kuwana M; Ikeda Y
Int J Hematol; 2005 Feb; 81(2):106-12. PubMed ID: 15765777
[TBL] [Abstract][Full Text] [Related]
3. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.
Kuwana M; Kaburaki J; Ikeda Y
J Clin Invest; 1998 Oct; 102(7):1393-402. PubMed ID: 9769332
[TBL] [Abstract][Full Text] [Related]
4. Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura.
Kuwana M; Kaburaki J; Kitasato H; Kato M; Kawai S; Kawakami Y; Ikeda Y
Blood; 2001 Jul; 98(1):130-9. PubMed ID: 11418472
[TBL] [Abstract][Full Text] [Related]
5. Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura.
Kuwana M; Okazaki Y; Kaburaki J; Kawakami Y; Ikeda Y
J Immunol; 2002 Apr; 168(7):3675-82. PubMed ID: 11907134
[TBL] [Abstract][Full Text] [Related]
6. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis.
Kajihara M; Kato S; Okazaki Y; Kawakami Y; Ishii H; Ikeda Y; Kuwana M
Hepatology; 2003 Jun; 37(6):1267-76. PubMed ID: 12774004
[TBL] [Abstract][Full Text] [Related]
7. [Recent topics on basic research for idiopathic thrombocytopenic purpura].
Kuwana M; Kawakami Y; Ikeda Y
Rinsho Byori; 2001 Oct; 49(10):992-5. PubMed ID: 11769478
[TBL] [Abstract][Full Text] [Related]
8. Platelet-associated anti-glycoprotein (GP) IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum autoantibodies.
Kosugi S; Tomiyama Y; Shiraga M; Kashiwagi H; Mizutani H; Kanakura Y; Kurata Y; Matsuzawa Y
Thromb Haemost; 1996 Feb; 75(2):339-45. PubMed ID: 8815587
[TBL] [Abstract][Full Text] [Related]
9. Suppression of autoreactive T-cell response to glycoprotein IIb/IIIa by blockade of CD40/CD154 interaction: implications for treatment of immune thrombocytopenic purpura.
Kuwana M; Kawakami Y; Ikeda Y
Blood; 2003 Jan; 101(2):621-3. PubMed ID: 12393517
[TBL] [Abstract][Full Text] [Related]
10. Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura.
Kuwana M; Nomura S; Fujimura K; Nagasawa T; Muto Y; Kurata Y; Tanaka S; Ikeda Y
Blood; 2004 Feb; 103(4):1229-36. PubMed ID: 14551140
[TBL] [Abstract][Full Text] [Related]
11. [Participation of bonth splenic CD(5)(+) and CD(5)(-) B lymphocytes in production of platelet glycoprotein-specific autoantibodies in chronic ITP].
Lu B; Hou M; Lu L; Shi Y; He Q; Ma D; Zhang M
Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):460-2. PubMed ID: 12482355
[TBL] [Abstract][Full Text] [Related]
12. The pathogenesis of chronic immune thrombocytopenic purpura.
McMillan R
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470
[TBL] [Abstract][Full Text] [Related]
13. [Significance of detection of anti-GPIIb/IIIa antibody secreting B cells and platelet-specific antibody in patients with idiopathic thrombocytopenic purpura].
Chen JF; Yang LH; Dong CX; Feng JJ; Liu XE; Lu YJ; Chang LX; Liu JQ
Zhonghua Xue Ye Xue Za Zhi; 2010 Sep; 31(9):603-6. PubMed ID: 21122320
[TBL] [Abstract][Full Text] [Related]
14. Platelet-associated antibody to glycoprotein IIb/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation-dependent antigens.
Fujisawa K; Tani P; McMillan R
Blood; 1993 Mar; 81(5):1284-9. PubMed ID: 7680243
[TBL] [Abstract][Full Text] [Related]
15. The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura.
McMillan R
Semin Hematol; 2000 Jan; 37(1 Suppl 1):5-9. PubMed ID: 10676917
[TBL] [Abstract][Full Text] [Related]
16. The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura.
Chan H; Moore JC; Finch CN; Warkentin TE; Kelton JG
Br J Haematol; 2003 Sep; 122(5):818-24. PubMed ID: 12930395
[TBL] [Abstract][Full Text] [Related]
17. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura.
Bettaieb A; Fromont P; Louache F; Oksenhendler E; Vainchenker W; Duédari N; Bierling P
Blood; 1992 Jul; 80(1):162-9. PubMed ID: 1611083
[TBL] [Abstract][Full Text] [Related]
18. Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
Najaoui A; Bakchoul T; Stoy J; Bein G; Rummel MJ; Santoso S; Sachs UJ
Eur J Haematol; 2012 Feb; 88(2):167-74. PubMed ID: 21985182
[TBL] [Abstract][Full Text] [Related]
19. [Advances in immunological aspects of idiopathic thrombocytopenic purpura].
Kuwana M
Nihon Rinsho; 2003 Apr; 61(4):670-5. PubMed ID: 12718094
[TBL] [Abstract][Full Text] [Related]
20. Anti-platelet antibodies associated with the Canale-Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purpura patients.
Grodzicky T; Bussel JB; Elkon KB
Clin Exp Immunol; 2002 Feb; 127(2):289-92. PubMed ID: 11876752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]